ReNerve Limited (ASX:RNV)
Australia flag Australia · Delayed Price · Currency is AUD
0.1100
-0.0050 (-4.35%)
At close: Jun 6, 2025, 4:00 PM AEST

ReNerve Company Description

ReNerve Limited, a medical device company, develops tissue-based products for peripheral nerve repair and replacement, and other related soft tissue surgical procedures.

It develops NervAlign Nerve Cuff, a protective wrap used to protect repaired injured nerves; NervAlign Nerve Graft, a size-based range of off-the-shelf nerve grafts for the repair of damaged nerves; and NervAlign bionic nerve to produce a replacement nerve that contains shaped ionic polymers, which would enable the stimulation of the distal end of a nerve injury.

The company was incorporated in 2016 and is headquartered in Northcote, Australia.

ReNerve Limited
Country Australia
Founded 2016
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
CEO Julian Chick

Contact Details

Address:
157 Heidelberg Road
Northcote, 3070
Australia
Phone 61 3 9482 3940
Website renerve.com.au

Stock Details

Ticker Symbol RNV
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
SIC Code 3842

Key Executives

Name Position
Julian Chick Chief Executive Officer
David Lilja Chief Financial Officer